In vivo nuclear magnetic resonance (NMR) At the time we began our NMR experiments, studies had indicated that, after a glucose load, glucose was consumed mainly in the muscle, where it was presumably stored as glycogen (2). It was thus believed that muscle was the principal site of insulin resistance in NIDDM. Measurements of the rate of muscle glycogen synthesis, however, were not sufficiently accurate to test this hypothesis directly. Our contribution to these studies consisted of providing accurate measurements of glycogen concentrations both in muscle and in liver by using 13C NMR. Glycogen in solution (3) and in vivo (4) gave wellresolved resonances in the 1 3C NMR spectra, which, when compared with those from standardized solutions, allowed quantitative determination of glycogen concentrations in vivo (5). This was unexpected for a large molecule like glycogen (molecular weight: 108 daltons) that ordinarily gives resonances too broad to be resolved. Subsequent chemical NMR experiments, however, showed that the glycogen molecule has uniformly rapid internal motion, thereby explaining its spectral visibility.
have slower glucose disposal rates than normal individuals. In early life, insulin resistance is counterbalanced by insulin overproduction by the pancreas; as a result, while young subjects often have impaired glucose tolerance, they are not substantially hyperglycemic. The disease develops later in life when insulin secretion no longer compensates for resistance. This "switch" depends upon body weight, diet, and exercise in ways not yet completely understood.
At the time we began our NMR experiments, studies had indicated that, after a glucose load, glucose was consumed mainly in the muscle, where it was presumably stored as glycogen (2) . It was thus believed that muscle was the principal site of insulin resistance in NIDDM. Measurements of the rate of muscle glycogen synthesis, however, were not sufficiently accurate to test this hypothesis directly. Our contribution to these studies consisted of providing accurate measurements of glycogen concentrations both in muscle and in liver by using 13C NMR. Glycogen in solution (3) and in vivo (4) gave wellresolved resonances in the 1 3C NMR spectra, which, when compared with those from standardized solutions, allowed quantitative determination of glycogen concentrations in vivo (5) . This was unexpected for a large molecule like glycogen (molecular weight: 108 daltons) that ordinarily gives resonances too broad to be resolved. Subsequent chemical NMR experiments, however, showed that the glycogen molecule has uniformly rapid internal motion, thereby explaining its spectral visibility.
The experiments reviewed here were all performed in a 2.1 -T magnet 1 m in diameter. Subjects were placed in the magnet by lying supine In our first experiments, 13C NMR measurements of muscle glycogen concentrations were obtained in subjects with NIDDM and in their age/weight-matched controls during a hyperinsulinemic-hyperglycemic clamp, which simulated post-prandial conditions ( Fig. 1) (6) . In both groups, total muscle glycogen synthesis was equal to total nonoxidative glucose consumption (Fig. 2) pleting exercise, glucose transporters are recruited from intracellular vesicles to the plasma membrane (8, 9) . This, in turn, facilitates diffusion of glucose into the cell, where it is converted to G6P. Insulin also controls another step in this pathway: the activity of the enzyme muscle glycogen synthase (GSase). This enzyme has four identical subunits each containing nine serines that can be phosphorylated and dephosphorylated by numerous kinases and phosphatases, thereby regulating its level of activity (10, 11 Hk activity in response to insulin has been strongly suggested (13) . Furthermore, there are several reports suggesting that the stimulation of glucose transport by insulin is reduced in NIDDM patients and their offsprings, based on reduced glucose uptake (14, 15) .
Despite this evidence indicating that reduced GT/Hk activity is responsible for reduced glucose consumption in NIDDM, the notion that GSase activity "controls" glycogenic flux in normal individuals has persevered. Surprisingly, experimental data provided little support for this view. Prior to our NMR studies, there was poor agreement between muscle GSase activity measured in human muscle biopsy samples and in vivo glycogenic flux. It was known from the early work of Piras and colleagues (16) that G6P is a positive allosteric effector of GSase. Their experiments showed that in vivo concentrations of ATP inhibited GSase and that this inhibition was overcome by G6P concentrations varying between -100 ,uM for the more active form of GSase to several millimolar for the less active form. However, difficulties in correlating GSase activities measured in human biopsy samples with flux had been confounded by G6P concentrations reported in biopsies which were too high to provide agreement with glucose uptake measurements (presumably due to extraction artifacts) (17) . Our 
GLYCOGEN SYNTHESIS AFTER EXERCISE
Intense exercise depletes glycogen and leads to a subsequent period of resynthesis (21) . Early biopsy measurements (22) indicated that after intense depletion, a rapid period of synthesis occurs during the first hour, followed by several hours of slower synthesis and gradual return to basal levels. In studies where exogenous insulin was administered to subjects with insulin-dependent diabetes mellitus, the rapid phase was shown to be insulin independent and the subsequent phase insulin dependent (22) .
These results have been confirmed and extended by our in vivo 13C NMR studies of healthy nondiabetic subjects. Rates of glycogen synthesis were derived from the slope of the curve obtained by plotting glycogen concentrations as a function of time (23) . The rapid phase of glycogen resynthesis was observed only after severe glycogen depletion (<25% of basal) and the period of slower resynthesis after less severe depletion (Fig. 5) . The transition from insulin-independent to insulin-dependent phases took place at -30 mM glucose equivalents. The insulindependent and -independent phases were identified by measurements using somatostatin infusion to inhibit insulin secretion. In the absence of insulin, the initial rapid phase was not affected, while the slower, later phase was completely inhibited (2 3). We then studied the effects of insulin resistance by determining glycogen synthesis rates after exercise that decreased muscle glycogen to -25% of basal levels in eight young, lean, normoglycemic, insulin-resistant offspring of par- 80T (24, 25) . Glycogen synthesis rates during the first hour after exercise, which is the insulin-independent recovery period, was the same in both groups (15.5 ± 1.3 mM/hr in insulin-resistant subjects and 15.8 ± 1.7 mM/hr in the controls). After the first hour, during the insulin-dependent period, glycogen synthesis rates in the insulin-resistant subjects were negligible but they were significantly higher in the controls. These results provide evidence that the early, rapid rate of glycogen resynthesis after glycogen-depleting exercise is not impaired in the insulin-resistant offspring of NIDDM parents but the later, insulin-dependent phase is considerably impaired.
NMR STUDIES OF HEPATIC GLYCOGEN IN NIDDM SUBJECTS AND CONTROLS
Since the 13C isotope measured in these NMR experiments is only 1. 1% naturally abundant, in our studies signal strength was sometimes improved by infusing subjects with substrates containing 13C (such as 1-_3C glucose). This type of labeling also permitted the measurement of turnover rates and thus to distinguish a kinetically inert glycogen pool from one that is continually being synthesized and degraded. In the muscle, our experiments showed that the glycogen pool at rest was static. In a series of experiments using fed and fasted healthy nondiabetic subjects, we showed that the rate of hepatic glycogen degradation, or glycogenolysis, increased with higher glycogen concentrations. In a complementary fashion, the rate of glycogen synthesis decreased as glycogen concentrations increased. Thus, the resting level of hepatic glycogen is in a dynamic steady state where synthesis equals degradation (27) .
It is well known that the rate of hepatic glucose production is higher in diabetics. In order to determine the individual contributions of gluconeogenesis and glycogenolysis to hepatic glucose production, we used 13C NMR methods.
Experiments were conducted first in a group of nondiabetic human subjects in order to establish the methodology and then repeated in another cohort of subjects with NIDDM and their age/ weight-matched controls. Measurements taken in the first experiments (28) on young normal subjects during a 68-hr fast, were based on a model whereby hepatic glucose production is equal to gluconeogenic flux plus glycogenolytic flux. Rates of total glucose production were calculated by infusing 6-3H-labeled glucose during the fast and measuring the decrease in radioactivity as unlabeled glucose was produced. Glycogenolysis rates were determined by measuring hepatic glycogen by 13C NMR as a function of time (Fig. 6) . In order to measure total hepatic glycogen, volumetric measurements by magnetic resonance imaging (MRI) were taken several times during the fast to correct the 13C NMR intensities which measured glycogen concentrations by changes in liver volume. Gluconeogenesis accounted for 64 ± 5% of total glucose production during the first 22 hr of the fast. In the subsequent 14-and 18-hr periods, gluconeogenesis accounted for 82 ± 5% and 96 ± 1%, respectively, of total glucose production. Based on these in vivo measurements, gluconeogenesis accounted for a larger fraction of glucose production than had been previously reported.
In a similar study using NIDDM patients in 3 . This reduced activity of GT/Hk is a genetic defect present before the clinical onset of disease in prediabetic descendants of diabetic parents. 4 . In muscle from normal, healthy subjects the rate of glycogen synthesis is controlled by the glucose transport/hexokinase activity step and not by the activity of the muscle glycogen synthase enzyme. 5 . Hepatic gluconeogenesis is responsible for most hepatic glucose production during an overnight fast in both normal and NIDDM subjects, and increases in gluconeogenic flux are responsible for the increased rate of hepatic glucose production in NIDDM subjects. 6 . In contrast to human muscle, where glycogenesis ceases at rest, in the liver gluconeogenesis and glycogenolysis are always active.
Numerous previous studies were considered prior to embarking in each of these NMR experiments. In the original research articles we published, the earlier studies were discussed in terms of the relevant literature. Here, however, I have chosen to present the NMR data as simply as possible, in the hope of exposing the significance of these studies by disentangling the results from the complexities of NMR methodology.
